Matches in Wikidata for { <http://www.wikidata.org/entity/Q82812951> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q82812951 description "artículu científicu espublizáu en xunu de 1972" @default.
- Q82812951 description "im Juni 1972 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82812951 description "scientific article published on 01 June 1972" @default.
- Q82812951 description "wetenschappelijk artikel" @default.
- Q82812951 description "наукова стаття, опублікована в червні 1972" @default.
- Q82812951 name "Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574)" @default.
- Q82812951 name "Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574)" @default.
- Q82812951 type Item @default.
- Q82812951 label "Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574)" @default.
- Q82812951 label "Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574)" @default.
- Q82812951 prefLabel "Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574)" @default.
- Q82812951 prefLabel "Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574)" @default.
- Q82812951 P1433 Q82812951-A37E58C9-261D-4860-B386-9ADF7D2738E2 @default.
- Q82812951 P1476 Q82812951-C1B208E5-2D70-487A-A701-BC506F66B499 @default.
- Q82812951 P2093 Q82812951-1BD9E791-3BE4-4E0E-9D56-44A1F55545F8 @default.
- Q82812951 P2093 Q82812951-B86EDA87-7963-4CFC-8C7E-5466DAA81864 @default.
- Q82812951 P2093 Q82812951-C2F27D6A-E51A-4435-85D5-DF6559ABAB6B @default.
- Q82812951 P304 Q82812951-D95AD501-45F5-42FF-91E4-83C503A6CB8C @default.
- Q82812951 P31 Q82812951-323F24C2-250B-4BC3-B96B-0900B7BDC420 @default.
- Q82812951 P433 Q82812951-B2A2F4E2-0CB4-4B37-84E2-59020AA85612 @default.
- Q82812951 P478 Q82812951-709485E8-FD50-43AB-B81A-9066EBB000BF @default.
- Q82812951 P577 Q82812951-DB06C188-4D20-4336-9C1E-DD3C75D5FABD @default.
- Q82812951 P698 Q82812951-3E5CA86B-3D06-4A19-8E51-EEAE7EDF2EA8 @default.
- Q82812951 P921 Q82812951-BD786CED-2C2F-4507-B051-31E0D0E92B6D @default.
- Q82812951 P698 19051495 @default.
- Q82812951 P1433 Q27710278 @default.
- Q82812951 P1476 "Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574)" @default.
- Q82812951 P2093 "D H Cowan" @default.
- Q82812951 P2093 "S Gardere" @default.
- Q82812951 P2093 "S Hussain" @default.
- Q82812951 P304 "357-361" @default.
- Q82812951 P31 Q13442814 @default.
- Q82812951 P433 "3" @default.
- Q82812951 P478 "56" @default.
- Q82812951 P577 "1972-06-01T00:00:00Z" @default.
- Q82812951 P698 "19051495" @default.
- Q82812951 P921 Q416975 @default.